Ampio Pharmaceuticals, Inc. (AMPE)

NYSEAMERICAN: AMPE · IEX Real-Time Price · USD
0.103
+0.000 (0.10%)
At close: Aug 17, 2022 4:00 PM
0.105
+0.002 (1.843%)
Pre-market: Aug 18, 2022 6:09 AM EDT

Ratios and Metrics (Annual)

Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Current2021202020192018201720162015201420132012 2011 - 2010
Market Capitalization
23115294924230951182178298133
Upgrade
Market Cap Growth
--60.84%218.13%119.53%-86.37%500.47%-71.72%2.09%-40.17%124.26%8.02%
Upgrade
Enterprise Value
182278873530146166128272115
Upgrade
PE Ratio
--6.75-18.51-6.791.24-5.96-2.69-7.55-5.69-12.41-11.46
Upgrade
PS Ratio
---------5959.172657.30
Upgrade
PB Ratio
1.164.2216.8014.368.05-9.047.764.922.709.015.58
Upgrade
EV/Sales Ratio
---------5317.362251.28
Upgrade
EV/EBITDA Ratio
----0.95------
Upgrade
EV/EBIT Ratio
----0.98------
Upgrade
Debt / Equity Ratio
0.020.020.050.190.09------
Upgrade
Debt / EBITDA Ratio
-0.03-0.04-0.06-0.100.01------
Upgrade
Debt / FCF Ratio
-0.02-0.04-0.06-0.08-0.04------
Upgrade
Current Ratio
4.856.9610.081.935.802.182.535.3013.9310.6910.91
Upgrade
Asset Turnover
-000000000.000.00
Upgrade
Return on Equity (ROE)
-80.80%-83.60%-173.80%-256.90%-2638.40%810.10%-161.50%-49.80%-40.80%-85.50%-58.40%
Upgrade
Return on Assets (ROA)
-57.90%-62.20%-107.50%-85.90%243.00%-427.00%-111.70%-42.30%-38.50%-77.60%-53.90%
Upgrade
Return on Capital (ROIC)
-2567.90%-528.80%-343.10%-223.70%754.80%-1046.80%-272.20%-116.70%-228.00%-391.00%-177.60%
Upgrade
Earnings Yield
-75.30%-14.80%-5.40%-14.70%80.70%-16.80%-37.20%-13.20%-17.60%-8.10%-8.70%
Upgrade
FCF Yield
-79.40%-12.30%-5.00%-16.70%-30.20%-3.70%-28.40%-14.60%-22.10%-6.90%-7.30%
Upgrade
Buyback Yield / Dilution
-12.23%-18.58%-31.81%-43.96%-39.50%-21.43%-3.43%-3.52%-31.16%-12.68%-30.64%
Upgrade
Total Shareholder Return
-12.23%-18.58%-31.81%-43.96%-39.50%-21.43%-3.43%-3.52%-31.16%-12.68%-30.64%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).